Business
Cyduct Diagnostics Recognizes a Visionary Leader in Breast Health: Dr. Susan Love
Cyduct Diagnostics Recognizes a Visionary Leader in Breast Health: Dr. Susan Love.
About this update from Cyduct Diagnostics Inc.
[{"type":"text","content":"WESTPORT, CT / ACCESSWIRE / August 1, 2023 / CYduct Diagnostics, Inc. (OTCPK:CYDX) ("CYduct" or the "Company"), - CYduct Diagnostics an emerging force in women's breast health would like to recognize the immeasurable impact that Dr. Susan Love, a visionary leader in defining solutions for breast disease had on our company. Dr. Susan Love, who recently passed, had an untiring dedication to advancing medical diagnostics and her invaluable knowledge have left an indelible mark on our organization and the entire healthcare community.Dom Gatto, CEO of CYduct Diagnostics stated: "I had the privilege of working with Dr. Susan Love over the years. Her passion for research and unwavering commitment to improving patient outcomes have been an inspiration to us all. Dr. Love's contributions in the field of Breast Health and persistence in challenging the status quo, have not only elevated the standard of care but also helped pave the way for revolutionary breakthroughs in early detection and treatment."Dr. Love was influential in the formation of CYduct Diagnostics, generously sharing her expertise and advice during the company's formative beginnings. Her visionary thinking and willingness to explore new avenues greatly influenced the development of our cutting-edge technologies and diagnostic solutions. Her profound understanding of the intricacies of the human breast and its diseases has been the cornerstone of our research and innovation."Dr. Susan Love brought breast clinicians, researchers, and patients together to collaborate and problem solve. These teams are the most successful when it comes to tackling questions that need to be answered about breast cancer. The Dr. Susan Love Foundation for Breast Cancer Research helps these teams move from an idea to a commercialized product that can change the lives of thousands of people. I feel blessed to have met her and her team and honored that the CYduct team was chosen for one of the Susan Love Foundation grants this year", stated Dr. Jill Dietz Chief Medical Director of CYduct Diagnostics.Throughout her illustrious career, Dr. Love displayed an unwavering commitment to patient advocacy, empowering individuals to take charge of their health and fostering a sense of community within the breast healthcare field. Her genuine concern for patient well-bei...